Bausch Health Companies Inc

BHC NYSE
21.30
+0.42
+2.01%
After Hours: 21.58 +0.28 +1.29% 19:42 08/16 EDT
Open
21.01
Prev Close
20.88
High
21.48
Low
20.90
Volume
2.72M
Avg Vol (3M)
3.39M
52 Week High
28.45
52 Week Low
17.20
% Turnover
0.77%
Market Cap
7.50B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Bausch Health Companies Inc BHC stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
MORE >

Recently

Name
Price
%Change